Was having a peruse on market screener yesterday of the aussie bank price to book ratios. Then had a look at HGH and it was a bit higher, 25bp-30bp higher. (Aside from CBA which was 100bp more than the rest.)
HGH a bit pricey?
Printable View
Was having a peruse on market screener yesterday of the aussie bank price to book ratios. Then had a look at HGH and it was a bit higher, 25bp-30bp higher. (Aside from CBA which was 100bp more than the rest.)
HGH a bit pricey?
Waiting for your dairy price correlation comment W69?
Cheap on an earnings basis, especially relative to average expectations of earnings growth in the next few years compared to their peers, see post #14,970 but as noted in subsequent posts they will take a hit from losses with Auckland business's.
Probably very close to fair value all things considered at present.
https://www.nzherald.co.nz/business/...VOUQBEGAGAANI/
Heaps more funding for Harmoney. Lending more than $100m more on an unsecured basis during a Covid crisis...what could possibly go wrong lol
Well they just sold $100m of loans taken out in a covid crisis to someone else. Now they can relend that $100m into a market emerging from a covid crisis. With libra those new loans are far cheaper to process and offer less risk of default. Sounds like good business to me.
The banks buying into HMYs securitization program is really them waving the white flag and realizing it’s better and easier to get further consumer lending exposure via HMY than going to the market with their clunky 5 day turnaround manual process.
Much the same reason why HGH securitization program is so popular (and the countries largest). Banks can buy in and get asset finance exposure without investing big into a proper asset finance division